Amyris Analyst Ratings
Amyris Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/19/2022 | 54.44% | Piper Sandler | $2.5 → $4 | Maintains | Neutral |
| 08/10/2022 | -22.78% | Roth Capital | → $2 | Downgrades | Buy → Neutral |
| 06/24/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 05/25/2022 | -3.47% | Piper Sandler | → $2.5 | Initiates Coverage On | → Neutral |
| 08/06/2021 | 749.42% | Roth Capital | $25 → $22 | Maintains | Buy |
| 08/06/2021 | 903.86% | Oppenheimer | $25 → $26 | Maintains | Outperform |
| 08/06/2021 | 1058.3% | HC Wainwright & Co. | $35 → $30 | Maintains | Buy |
| 06/01/2021 | 672.2% | HSBC | → $20 | Initiates Coverage On | → Buy |
| 03/03/2021 | 1174.13% | Roth Capital | $20 → $33 | Maintains | Buy |
| 03/03/2021 | 1251.35% | HC Wainwright & Co. | $11 → $35 | Maintains | Buy |
| 02/26/2021 | 672.2% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 01/06/2021 | 247.49% | Cowen & Co. | → $9 | Upgrades | Market Perform → Outperform |
| 11/25/2020 | 93.05% | Cowen & Co. | → $5 | Initiates Coverage On | → Market Perform |
| 11/25/2020 | 29.34% | Jefferies | → $3.35 | Initiates Coverage On | → Buy |
| 12/12/2019 | 208.88% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
| 03/20/2018 | 286.1% | B. Riley Securities | $8 → $10 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 11/09/2022 | - | 奧本海默 | 評級下調 | 超越→表現 | |
| 2022/09/19 | 54.44% | 派珀·桑德勒 | $2.5→$4 | 維護 | 中性 |
| 2022年08月10日 | -22.78% | 羅斯資本 | →$2 | 評級下調 | 購買→中性 |
| 2022/06/24 | - | 摩根大通 | 開始承保 | →中性 | |
| 2022年05月25日 | -3.47% | 派珀·桑德勒 | →$2.5 | 開始承保 | →中性 |
| 08/06/2021 | 749.42% | 羅斯資本 | $25→$22 | 維護 | 買 |
| 08/06/2021 | 903.86% | 奧本海默 | $25→$26 | 維護 | 跑贏大盤 |
| 08/06/2021 | 1058.3% | HC Wainwright公司 | $35→$30 | 維護 | 買 |
| 06/01/2021 | 672.2% | 匯豐銀行 | →$20 | 開始承保 | →購買 |
| 03/03/2021 | 1174.13% | 羅斯資本 | $20→$33 | 維護 | 買 |
| 03/03/2021 | 1251.35% | HC Wainwright公司 | $11→$35 | 維護 | 買 |
| 02/26/2021 | 672.2% | 羅斯資本 | →$20 | 開始承保 | →購買 |
| 01/06/2021 | 247.49% | 考恩公司 | →$9 | 升級 | 市場表現優於→ |
| 11/25/2020 | 93.05% | 考恩公司 | →$5 | 開始承保 | →市場表現 |
| 11/25/2020 | 29.34% | 傑富瑞 | →$3.35 | 開始承保 | →購買 |
| 2019年12月12日 | 208.88% | 奧本海默 | →$8 | 開始承保 | →跑贏大盤 |
| 2018年3月20日 | 286.1% | B.萊利證券 | $8→$10 | 維護 | 買 |
Amyris Questions & Answers
阿米裡斯問答
The latest price target for Amyris (NASDAQ: AMRS) was reported by Oppenheimer on November 9, 2022. The analyst firm set a price target for $0.00 expecting AMRS to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
奧本海默於2022年11月9日報道了阿米裡斯(納斯達克：AMRS)的最新目標價。這家分析公司將目標價定為0.00美元，預計AMR將在12個月內下降(跌幅可能為-100.00%)。去年有5家分析公司公佈了評級。
The latest analyst rating for Amyris (NASDAQ: AMRS) was provided by Oppenheimer, and Amyris downgraded their perform rating.
奧本海默提供了對艾米瑞斯(納斯達克：AMRS)的最新分析師評級，艾米裡斯下調了其表現評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amyris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amyris was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Amyris的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Amyris的上一次評級是在2022年11月9日提交的，所以你應該預計下一次評級將在2023年11月9日左右提供。
While ratings are subjective and will change, the latest Amyris (AMRS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Amyris (AMRS) is trading at is $2.59, which is out of the analyst's predicted range.
雖然評級是主觀的，而且會發生變化，但最新的Amyris(AMRS)評級被下調，目標價在0.00美元至0.00美元之間。目前Amyris的交易價格為2.59美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。